| pubmed-article:12108747 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C0019944 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C0010092 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C0008013 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C0162518 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C1511572 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C1516695 | lld:lifeskim |
| pubmed-article:12108747 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
| pubmed-article:12108747 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12108747 | pubmed:dateCreated | 2002-7-10 | lld:pubmed |
| pubmed-article:12108747 | pubmed:abstractText | This study investigated the chemotactic activity of equine CL at different stages of the oestrous cycle. The purpose of this was to ascertain whether luteal tissue itself contributes to the massive influx of leucocytes around the time of natural and induced luteal regression. Corpora lutea were collected at different stages of dioestrus and after treatment with PGF2alpha. Culture medium harvested after incubation of luteal tissue for 20 h was chemotactic for both polymorphonuclear and mononuclear cells in late dioestrus (before functional regression) as well as after natural and induced luteal regression. By contrast, midluteal tissue showed no chemotactic activity. This is the first report of the ability of equine luteal tissue actively to recruit inflammatory cells in vitro and supports our earlier findings that this infiltration starts prior to functional luteolysis. We hypothesise that this early influx of inflammatory cells may play an active role in luteal regression. Further research is needed to identify the specific chemotactic factor(s). | lld:pubmed |
| pubmed-article:12108747 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12108747 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12108747 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12108747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12108747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12108747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12108747 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12108747 | pubmed:month | May | lld:pubmed |
| pubmed-article:12108747 | pubmed:issn | 0425-1644 | lld:pubmed |
| pubmed-article:12108747 | pubmed:author | pubmed-author:WatsonE DED | lld:pubmed |
| pubmed-article:12108747 | pubmed:author | pubmed-author:LawlerD FDF | lld:pubmed |
| pubmed-article:12108747 | pubmed:author | pubmed-author:BrazilT JTJ | lld:pubmed |
| pubmed-article:12108747 | pubmed:author | pubmed-author:DagleishM PMP | lld:pubmed |
| pubmed-article:12108747 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12108747 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:12108747 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12108747 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12108747 | pubmed:pagination | 279-82 | lld:pubmed |
| pubmed-article:12108747 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:meshHeading | pubmed-meshheading:12108747... | lld:pubmed |
| pubmed-article:12108747 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12108747 | pubmed:articleTitle | Chemoattractant properties of conditioned medium from equine corpora lutea collected at various stages of the oestrous cycle. | lld:pubmed |
| pubmed-article:12108747 | pubmed:affiliation | University of Edinburgh, Department of Veterinary Clinical Studies, Easter Bush, Midlothian, UK. | lld:pubmed |
| pubmed-article:12108747 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12108747 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:12108747 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12108747 | lld:pubmed |
